Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rose-Hip Vital is an Australian-owned company that specializes in the development and distribution of scientifically backed rosehip-based supplements for humans and animals. The company's flagship products are powered by GOPO, a patented galactolipid extracted from the Rosa canina plant through a specialized manufacturing process that preserves its anti-inflammatory properties. Their formulations are clinically proven to reduce joint pain and stiffness associated with osteoarthritis while supporting overall immune health. Rose-Hip Vital maintains a strong presence in the veterinary market with dedicated lines for canine and equine health. The company distinguishes itself through a commitment to rigorous clinical research, with numerous peer-reviewed studies supporting the efficacy of its specialized rosehip powder.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rose-Hip Vital.